additional navigation


You are here:

AOP Orphan in portraits

Success through experience and competence

We at AOP Orphan are European pioneers in the field of Orphan Diseases. We research, develop, produce, and distribute innovative solutions for Rare Diseases worldwide.

Dr. Rudolf Widmann established AOP Orphan in Vienna in 1996 in order to provide individualized treatment for patients suffering from Rare Diseases. AOP Orphan has focused particularly on the areas of hematology and oncology, cardiology, neurology, psychiatry and metabolic diseases.

Thanks to years of experience in providing complex individualized treatment, AOP Orphan has acquired significant expertise and developed a strong market presence in the field of Orphan Diseases. The fact that AOP Orphan is privately owned assures a long-term engagement in the market along with high quality services and products. AOP Orphan is also the only provider of key therapies for certain special indications.

AOP Orphan experts work closely with level with leading health care professionals at an international level. This has given them the ability to react quickly to needs and developments and to push research and development projects. When implementing these projects, AOP Orphan has a worldwide network of highly qualified partners that it can reach out to. These strategic alliances make sure that AOP Orphan, as a medium-sized company, is able to compete with top pharmaceutical companies.

Today AOP Orphan is active at an international level with an export ratio of about 70% and has become a leading company in its home market.

Vision & Strategy

For many years large pharmaceutical companies paid little attention to Orphan Diseases and to the plight of those unfortunate patients afflicted by them. However at AOP Orphan, we recognized the urgent need of these patients and saw an entrepreneurial opportunity to operate successfully in this small segment.

continue to Vision & Strategy

Facts & Figures

Being one of Europe’s leading suppliers in the field of Orphan Diseases has turned AOP Orphan into a pioneering Austrian company, where economic success and personal commitment go hand in hand.

continue to Facts & Figures


Led by the founder Dr. Rudolf Widmann, highly skilled experts form a powerful management team boasting a variety of personalities with different strengths and perspectives.

continue to Management


Since being founded in 1996, AOP Orphan has been continuously growing and expanding its area of operations — spreading from its headquarters in Vienna to Eastern and Western Europe, and from Europe to the rest of the world.

continue to Locations


Partnering is of key importance to AOP Orphan. One the one hand, it enables AOP Orphan to widen its sphere of influence beyond the core markets in Europe. On the other, it forms the basis for developing the portfolio.

continue to Partnerships


At AOP Orphan, corporate responsibility is an essential part of our philosophy that has played an indispensable role since the very beginning.

continue to CSR


AOP Orphan Pharmaceuticals AG
Representative office for the Baltic states
Didzioji st. 25, LT-01128 Vilnius
Tel +370 672 12222
Fax +370 5 2755203

Products & Area of treatment